Edward T Mathers is of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 3,000 shares of RYTM, which is worth approximately $179,820. The most recent transaction as insider was on Jun 21, 2024, when has been sold 3,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K
0% 3M change
n/a 12M change
Total Value Held $179,820

Edward T Mathers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
BUY
Exercise of conversion of derivative security
-
3,000 Added 50.0%
3,000 Common Stock

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SYBX
SYNLOGIC, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
INZY
Inozyme Pharma, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
SNTI
Senti Biosciences, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
ETM

Edward T Mathers

Timonium, MD

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM